Download PDF
Semin Reprod Med 2014; 32(03): 194-201
DOI: 10.1055/s-0034-1371091
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence

Sophia E. Agapova
1   Division of Pediatric Endocrinology, Diabetes, and Metabolism, Department of Pediatrics, Columbia University Medical Center, New York, New York
,
Tamara Cameo
1   Division of Pediatric Endocrinology, Diabetes, and Metabolism, Department of Pediatrics, Columbia University Medical Center, New York, New York
,
Aviva B. Sopher
1   Division of Pediatric Endocrinology, Diabetes, and Metabolism, Department of Pediatrics, Columbia University Medical Center, New York, New York
,
Sharon E. Oberfield
1   Division of Pediatric Endocrinology, Diabetes, and Metabolism, Department of Pediatrics, Columbia University Medical Center, New York, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
08 April 2014 (online)

    Permissions and Reprints

Abstract

Although the diagnostic criteria for polycystic ovary syndrome (PCOS) have become less stringent over the years, determination of the minimum diagnostic features in adolescents is still an area of controversy. Of particular concern is that many of the features considered to be diagnostic for PCOS may evolve over time and change during the first few years after menarche. Nonetheless, attempts to define young women who may be at risk for development of PCOS is pertinent since associated morbidity such as obesity, insulin resistance, and dyslipidemia may benefit from early intervention. The relative utility of diagnostic tools such as persistence of anovulatory cycles, hyperandrogenemia, hyperandrogenism (hirsutism, acne, or alopecia), or ovarian findings on ultrasound is not established in adolescents. Some suggest that even using the strictest criteria, the diagnosis of PCOS may not valid in adolescents younger than 18 years. In addition, evidence does not necessarily support that lack of treatment of PCOS in younger adolescents will result in untoward outcomes since features consistent with PCOS often resolve with time. The presented data will help determine if it is possible to establish firm criteria which may be used to reliably diagnose PCOS in adolescents.

Keywords

polycystic ovary syndrome - polycystic ovarian morphology - type 2 diabetes mellitus
 

  • References

  • 1 Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, , eds. Polycystic Ovary Syndrome. Boston, MA: Blackwell Scientific; 1992: 377-384
    Google Scholar
  • 2 Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333 (13) 853-861
    CrossrefPubMedGoogle Scholar
  • 3 National Institutes of Health. Evidence-Based Methodology Workshop on Polycystic Ovary Syndrome: Executive Summary. Washington: National Institutes of Health; 2012
    Google Scholar
  • 4 Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol 2011; 4 (2) 45-51
    PubMedGoogle Scholar
  • 5 Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19 (1) 1-7
    CrossrefPubMedGoogle Scholar
  • 6 Azziz R, Carmina E, Dewailly D , et al; Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91 (11) 4237-4245
    Google Scholar
  • 7 Ben Salem Hachmi L, Ben Salem Hachmi S, Bouzid C , et al. Hypertension in polycystic ovary syndrome [in French]. Arch Mal Coeur Vaiss 2006; 99 (7-8) 687-690
    PubMedGoogle Scholar
  • 8 Hoppin AG, Katz ES, Kaplan LM, Lauwers GY. Case records of the Massachusetts General Hospital. Case 31-2006. A 15-year-old girl with severe obesity. N Engl J Med 2006; 355 (15) 1593-1602
    CrossrefPubMedGoogle Scholar
  • 9 Mortensen M, Rosenfield RL, Littlejohn E. Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab 2006; 91 (10) 3786-3790
    CrossrefPubMedGoogle Scholar
  • 10 Harris YS, McDonald SB. An African American female with irregular menses and weight gain. Pediatr Nurs 2006; 32 (4) 354-357
    PubMedGoogle Scholar
  • 11 De Leo V, Musacchio MC, Morgante G, Piomboni P, Petraglia F. Metformin treatment is effective in obese teenage girls with PCOS. Hum Reprod 2006; 21 (9) 2252-2256
    CrossrefPubMedGoogle Scholar
  • 12 Glueck CJ, Aregawi D, Winiarska M , et al. Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab 2006; 19 (6) 831-842
    PubMedGoogle Scholar
  • 13 Glueck CJ, Morrison JA, Friedman LA, Goldenberg N, Stroop DM, Wang P. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabolism 2006; 55 (4) 508-514
    CrossrefPubMedGoogle Scholar
  • 14 Fulghesu AM, Angioni S, Portoghese E , et al. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome. Fertil Steril 2006; 86 (2) 398-404
    CrossrefPubMedGoogle Scholar
  • 15 Nicoletti A. Paradigm shift. J Pediatr Adolesc Gynecol 2006; 19 (4) 317-318
    CrossrefPubMedGoogle Scholar
  • 16 Vambergue A, Lautier C, Valat AS, Cortet-Rudelli C, Grigorescu F, Dewailly D. Follow-up study of two sisters with type A syndrome of severe insulin resistance gives a new insight into PCOS pathogenesis in relation to puberty and pregnancy outcome: a case report. Hum Reprod 2006; 21 (5) 1274-1278
    CrossrefPubMedGoogle Scholar
  • 17 Leibel NI, Baumann EE, Kocherginsky M, Rosenfield RL. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. J Clin Endocrinol Metab 2006; 91 (4) 1275-1283
    CrossrefPubMedGoogle Scholar
  • 18 Mastorakos G, Koliopoulos C, Deligeoroglou E, Diamanti-Kandarakis E, Creatsas G. Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. Fertil Steril 2006; 85 (2) 420-427
    CrossrefPubMedGoogle Scholar
  • 19 Yoo RY, Dewan A, Basu R, Newfield R, Gottschalk M, Chang RJ. Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism. Fertil Steril 2006; 85 (4) 1049-1056
    CrossrefPubMedGoogle Scholar
  • 20 Bridger T, MacDonald S, Baltzer F, Rodd C. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome. Arch Pediatr Adolesc Med 2006; 160 (3) 241-246
    CrossrefPubMedGoogle Scholar
  • 21 Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006; 91 (2) 492-497
    CrossrefPubMedGoogle Scholar
  • 22 Triantafyllopoulou M, Whitington PF, Melin-Aldana H, Benya EC, Brickman W. Hepatic adenoma in an adolescent with elevated androgen levels. J Pediatr Gastroenterol Nutr 2007; 44 (5) 640-642
    CrossrefPubMedGoogle Scholar
  • 23 Demirel F, Bideci A, Cinaz P , et al. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2007; 67 (1) 129-134
    CrossrefPubMedGoogle Scholar
  • 24 Sun L, Fu Q. Three-dimensional transrectal ultrasonography in adolescent patients with polycystic ovarian syndrome. Int J Gynaecol Obstet 2007; 98 (1) 34-38
    CrossrefPubMedGoogle Scholar
  • 25 Luque-Ramírez M, Alvarez-Blasco F, Mendieta-Azcona C, Botella-Carretero JI, Escobar-Morreale HF. Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92 (6) 2141-2148
    CrossrefPubMedGoogle Scholar
  • 26 Nazari T, Bayat R, Hamedi M. Metformin therapy in girls with polycystic ovary syndrome: a self-controlled clinical trial. Arch Iran Med 2007; 10 (2) 176-181
    PubMedGoogle Scholar
  • 27 Littlejohn EE, Weiss RE, Deplewski D, Edidin DV, Rosenfield R. Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome. J Pediatr Endocrinol Metab 2007; 20 (1) 41-51
    CrossrefPubMedGoogle Scholar
  • 28 Sharquie KE, Al-Bayatti AA, Al-Ajeel AI, Al-Bahar AJ, Al-Nuaimy AA. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome. Saudi Med J 2007; 28 (7) 1039-1043
    PubMedGoogle Scholar
  • 29 Chen MJ, Yang WS, Yang JH, Chen CL, Ho HN, Yang YS. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension 2007; 49 (6) 1442-1447
    CrossrefPubMedGoogle Scholar
  • 30 Rachmiel M, Kives S, Atenafu E, Hamilton J. Primary amenorrhea as a manifestation of polycystic ovarian syndrome in adolescents: a unique subgroup?. Arch Pediatr Adolesc Med 2008; 162 (6) 521-525
    CrossrefPubMedGoogle Scholar
  • 31 Bhattacharya SM. Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria. J Obstet Gynaecol Res 2008; 34 (1) 62-66
    PubMedGoogle Scholar
  • 32 Ibáñez L, López-Bermejo A, Callejo J , et al. Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth. J Clin Endocrinol Metab 2008; 93 (1) 196-199
    CrossrefPubMedGoogle Scholar
  • 33 Valdés P, Cerda A, Barrenechea C, Kehr M, Soto C, Salazar LA. No association between common Gly972Arg variant of the insulin receptor substrate-1 and polycystic ovary syndrome in Southern Chilean women. Clin Chim Acta 2008; 390 (1-2) 63-66
    CrossrefPubMedGoogle Scholar
  • 34 Rossi B, Sukalich S, Droz J , et al. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93 (12) 4780-4786
    CrossrefPubMedGoogle Scholar
  • 35 Fruzzetti F, Perini D, Lazzarini V, Parrini D, Genazzani AR. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril 2009; 92 (2) 626-634
    CrossrefPubMedGoogle Scholar
  • 36 Hart R, Doherty DA, Norman RJ , et al. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril 2010; 94 (3) 1118-1121
    CrossrefPubMedGoogle Scholar
  • 37 Huang J, Ni R, Chen X, Huang L, Mo Y, Yang D. Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China. Reprod Biol Endocrinol 2010; 8: 142
    CrossrefPubMedGoogle Scholar
  • 38 Shah B, Parnell L, Milla S, Kessler M, David R. Endometrial thickness, uterine, and ovarian ultrasonographic features in adolescents with polycystic ovarian syndrome. J Pediatr Adolesc Gynecol 2010; 23 (3) 146-152
    CrossrefPubMedGoogle Scholar
  • 39 Li L, Chen X, Mo Y, Chen Y, Wenig M, Yang D. Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome. Wien Klin Wochenschr 2010; 122 (17–18) 519-524
    CrossrefPubMedGoogle Scholar
  • 40 Bekx MT, Connor EC, Allen DB. Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome. J Pediatr Adolesc Gynecol 2010; 23 (1) 7-10
    CrossrefPubMedGoogle Scholar
  • 41 Bhattacharya SM, Jha A. Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 'joint interim criteria'. J Obstet Gynaecol Res 2011; 37 (10) 1303-1307
    CrossrefPubMedGoogle Scholar
  • 42 Bronstein J, Tawdekar S, Liu Y, Pawelczak M, David R, Shah B. Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought. J Pediatr Adolesc Gynecol 2011; 24 (1) 15-20
    CrossrefPubMedGoogle Scholar
  • 43 Hart R, Doherty DA, Mori T , et al. Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome. Fertil Steril 2011; 95 (7) 2347-2353 , e1
    CrossrefPubMedGoogle Scholar
  • 44 Hickey M, Doherty DA, Atkinson H , et al. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod 2011; 26 (6) 1469-1477
    CrossrefPubMedGoogle Scholar
  • 45 Morrison JA, Glueck CJ, Daniels S, Wang P, Stroop D. Adolescent oligomenorrhea in a biracial schoolgirl cohort: a simple clinical parameter predicting impaired fasting glucose plus type 2 diabetes mellitus, insulin, glucose, insulin resistance, and centripetal obesity from age 19 to 25 years. Metabolism 2011; 60 (9) 1285-1293
    CrossrefPubMedGoogle Scholar
  • 46 Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol 2011; 24 (4) 223-227
    CrossrefPubMedGoogle Scholar
  • 47 Codner E, Villarroel C, Eyzaguirre FC , et al. Polycystic ovarian morphology in postmenarchal adolescents. Fertil Steril 2011; 95 (2) 702-706 , e1–e2
    CrossrefPubMedGoogle Scholar
  • 48 Jones GL, Hall JM, Lashen HL, Balen AH, Ledger WL. Health-related quality of life among adolescents with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 2011; 40 (5) 577-588
    CrossrefPubMedGoogle Scholar
  • 49 Ladson G, Dodson WC, Sweet SD , et al. The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study. Fertil Steril 2011; 95 (3) 1059-1066 , e1–e7
    CrossrefPubMedGoogle Scholar
  • 50 Forrester-Dumont K, Galescu O, Kolesnikov A , et al. Hyperandrogenism does not influence metabolic parameters in adolescent girls with PCOS. Int J Endocrinol 2012; 2012: 434830
    PubMedGoogle Scholar
  • 51 Nair MK, Pappachan P, Balakrishnan S, Leena ML, George B, Russell PS. Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls—a 2 year follow-up study. Indian J Pediatr 2012; 79 (Suppl. 01) S69-S73
    CrossrefPubMedGoogle Scholar
  • 52 Rahmanpour H, Jamal L, Mousavinasab SN, Esmailzadeh A, Azarkhish K. Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents. J Pediatr Adolesc Gynecol 2012; 25 (3) 208-212
    CrossrefPubMedGoogle Scholar
  • 53 Villa P, Rossodivita A, Sagnella F , et al. Ovarian volume and gluco-insulinaemic markers in the diagnosis of PCOS during adolescence. Clin Endocrinol (Oxf) 2013; 78 (2) 285-290
    CrossrefPubMedGoogle Scholar
  • 54 Pinola P, Lashen H, Bloigu A , et al. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study. Hum Reprod 2012; 27 (11) 3279-3286
    CrossrefPubMedGoogle Scholar
  • 55 Brown M, Park AS, Shayya RF, Wolfson T, Su HI, Chang RJ. Ovarian imaging by magnetic resonance in adolescent girls with polycystic ovary syndrome and age-matched controls. J Magn Reson Imaging 2013; 38 (3) 689-693
    CrossrefPubMedGoogle Scholar
  • 56 Li L, Chen X, He Z, Zhao X, Huang L, Yang D. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. J Pediatr Adolesc Gynecol 2012; 25 (6) 390-395
    CrossrefPubMedGoogle Scholar
  • 57 Geier LM, Bekx MT, Connor EL. Factors contributing to initial weight loss among adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2012; 25 (6) 367-370
    CrossrefPubMedGoogle Scholar
  • 58 Jakubowski KP, Black JJ, El Nokali NE , et al. Parents' readiness to change affects BMI reduction outcomes in adolescents with polycystic ovary syndrome. J Obes 2012; 2012: 298067
    PubMedGoogle Scholar
  • 59 Nandalike K, Agarwal C, Strauss T , et al. Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome. Sleep Med 2012; 13 (10) 1307-1312
    CrossrefPubMedGoogle Scholar
  • 60 Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: A randomized control trial. Int J Yoga 2012; 5 (2) 112-117
    CrossrefPubMedGoogle Scholar
  • 61 To WW, Wong MW. A comparison of bone mineral density in normal weight and obese adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2012; 25 (4) 248-253
    CrossrefPubMedGoogle Scholar
  • 62 Nidhi R, Padmalatha V, Nagarathna R, Ram A. Effect of a yoga program on glucose metabolism and blood lipid levels in adolescent girls with polycystic ovary syndrome. Int J Gynaecol Obstet 2012; 118 (1) 37-41
    CrossrefPubMedGoogle Scholar
  • 63 Ganie MA, Farooqui KJ, Bhat MA , et al. Pattern of urinary albumin excretion in normotensive young and adolescent Indian women with polycystic ovary syndrome. Indian J Endocrinol Metab 2012; 16 (2) 277-282
    CrossrefPubMedGoogle Scholar
  • 64 Sopher AB, Gerken AT, Blaner WS, Root JM, McMahon DJ, Oberfield SE. Metabolic manifestations of polycystic ovary syndrome in nonobese adolescents: retinol-binding protein 4 and ectopic fat deposition. Fertil Steril 2012; 97 (4) 1009-1015
    CrossrefPubMedGoogle Scholar
  • 65 Deveer R, Engin-Üstün Y, Uysal S , et al. Serum brain natriuretic peptide and C-reactive protein levels in adolescent with polycystic ovary syndrome. Gynecol Endocrinol 2012; 28 (8) 602-605
    CrossrefPubMedGoogle Scholar
  • 66 Eleftheriadou M, Michala L, Stefanidis K, Iliadis I, Lykeridou A, Antsaklis A. Exercise and sedentary habits among adolescents with PCOS. J Pediatr Adolesc Gynecol 2012; 25 (3) 172-174
    CrossrefPubMedGoogle Scholar
  • 67 Bechtold S, Dalla Pozza R, Putzker S , et al. Effect of antiandrogen treatment on bone density and bone geometry in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2012; 25 (3) 175-180
    CrossrefPubMedGoogle Scholar
  • 68 de Sousa G, Schlüter B, Menke T, Trowitzsch E, Andler W, Reinehr T. Longitudinal analyses of polysomnographic variables, serum androgens, and parameters of glucose metabolism in obese adolescents with polycystic ovarian syndrome. Sleep Breath 2012; 16 (4) 1139-1146
    CrossrefPubMedGoogle Scholar
  • 69 Pawelczak M, Kenigsberg L, Milla S, Liu YH, Shah B. Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features. J Pediatr Endocrinol Metab 2012; 25 (9-10) 983-989
    PubMedGoogle Scholar
  • 70 Roe AH, Prochaska E, Smith M, Sammel M, Dokras A. Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents. J Pediatr 2013; 162 (5) 937-941
    CrossrefPubMedGoogle Scholar
  • 71 Milsom SR, Nair SM, Ogilvie CM, Stewart JM, Merry SN. Polycystic ovary syndrome and depression in New Zealand adolescents. J Pediatr Adolesc Gynecol 2013; 26 (3) 142-147
    CrossrefPubMedGoogle Scholar
  • 72 Auble B, Elder D, Gross A, Hillman JB. Differences in the management of adolescents with polycystic ovary syndrome across pediatric specialties. J Pediatr Adolesc Gynecol 2013; 26 (4) 234-238
    CrossrefPubMedGoogle Scholar
  • 73 Zachurzok A, Deja G, Gawlik A, Drosdzol-Cop A, Małecka-Tendera E. Hyperandrogenism in adolescent girls with type 1 diabetes mellitus treated with intensive and continuous subcutaneous insulin therapy. Endokrynol Pol 2013; 64 (2) 121-128
    PubMedGoogle Scholar
  • 74 Jeon YE, Lee KE, Jung JA , et al. Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome. Gynecol Obstet Invest 2013; 75 (4) 268-274
    CrossrefPubMedGoogle Scholar
  • 75 Christensen SB, Black MH, Smith N , et al. Prevalence of polycystic ovary syndrome in adolescents. Fertil Steril 2013; 100 (2) 470-477
    CrossrefPubMedGoogle Scholar
  • 76 Kale-Gurbuz T, Akhan SE, Bastu E, Telci A, Iyibozkurt AC, Topuz S. Adiponectin, leptin and ghrelin levels in obese adolescent girls with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2013; 26 (1) 27-30
    CrossrefPubMedGoogle Scholar
  • 77 Bredella MA, McManus S, Misra M. Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome. Clin Endocrinol (Oxf) 2013; 79 (2) 199-203
    CrossrefPubMedGoogle Scholar
  • 78 Yin Q, Chen X, Li L, Zhou R, Huang J, Yang D. Apolipoprotein B/apolipoprotein A1 ratio is a good predictive marker of metabolic syndrome and pre-metabolic syndrome in Chinese adolescent women with polycystic ovary syndrome. J Obstet Gynaecol Res 2013; 39 (1) 203-209
    CrossrefPubMedGoogle Scholar
  • 79 Flannery CA, Rackow B, Cong X, Duran E, Selen DJ, Burgert TS. Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI. Pediatr Diabetes 2013; 14 (1) 42-49
    CrossrefPubMedGoogle Scholar
  • 80 Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol 2010; 203 (3) e1-e5
    CrossrefPubMedGoogle Scholar
  • 81 Hardy TS, Norman RJ. Diagnosis of adolescent polycystic ovary syndrome. Steroids 2013; 78 (8) 751-754
    CrossrefPubMedGoogle Scholar
  • 82 Sultan C, Paris F. Clinical expression of polycystic ovary syndrome in adolescent girls. Fertil Steril 2006; 86 (Suppl. 01) S6
    PubMedGoogle Scholar
  • 83 Fauser BC, Tarlatzis BC, Rebar RW , et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012; 97 (Suppl. 01) 28.e25-38.e25
    PubMedGoogle Scholar
  • 84 Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007; 92 (2) 405-413
    CrossrefPubMedGoogle Scholar
  • 85 Biro FM, Emans SJ. Whither PCOS? The challenges of establishing hyperandrogenism in adolescent girls. J Adolesc Health 2008; 43 (2) 103-105
    CrossrefPubMedGoogle Scholar
  • 86 Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring hirsutism. Hum Reprod Update 2010; 16 (1) 51-64
    Google Scholar
  • 87 Martin KA, Chang RJ, Ehrmann DA , et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93 (4) 1105-1120
    CrossrefPubMedGoogle Scholar
  • 88 Merino PM, Codner E, Cassorla F. A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence. Arq Bras Endocrinol Metabol 2011; 55 (8) 590-598
    CrossrefPubMedGoogle Scholar
  • 89 Legro RS, Schlaff WD, Diamond MP , et al; Reproductive Medicine Network. Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab 2010; 95 (12) 5305-5313
    CrossrefPubMedGoogle Scholar
  • 90 Janse F, Eijkemans MJ, Goverde AJ , et al. Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results. Eur J Endocrinol 2011; 165 (6) 925-933
    CrossrefPubMedGoogle Scholar
  • 91 Haring R, Hannemann A, John U , et al. Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 2012; 97 (2) 408-415
    CrossrefPubMedGoogle Scholar
  • 92 Kushnir MM, Blamires T, Rockwood AL , et al. Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals. Clin Chem 2010; 56 (7) 1138-1147
    CrossrefPubMedGoogle Scholar
  • 93 Fanelli F, Gambineri A, Belluomo I , et al. Androgen profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in healthy normal-weight ovulatory and anovulatory late adolescent and young women. J Clin Endocrinol Metab 2013; 98 (7) 3058-3067
    CrossrefPubMedGoogle Scholar
  • 94 Apter D, Vihko R. Serum pregnenolone, progesterone, 17-hydroxyprogesterone, testosterone and 5 alpha-dihydrotestosterone during female puberty. J Clin Endocrinol Metab 1977; 45 (5) 1039-1048
    CrossrefPubMedGoogle Scholar
  • 95 van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. Hum Reprod 2004; 19 (2) 383-392
    CrossrefPubMedGoogle Scholar
  • 96 Rosenfield RL. Clinical review: Adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab 2013; 98 (9) 3572-3583
    CrossrefPubMedGoogle Scholar
  • 97 Jeffrey Chang R, Coffler MS. Polycystic ovary syndrome: early detection in the adolescent. Clin Obstet Gynecol 2007; 50 (1) 178-187
    CrossrefPubMedGoogle Scholar
  • 98 Hassan A, Gordon CM. Polycystic ovary syndrome update in adolescence. Curr Opin Pediatr 2007; 19 (4) 389-397
    CrossrefPubMedGoogle Scholar
  • 99 Dewailly D, Gronier H, Poncelet E , et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Human Reprod 2001; 26 (11) 3123-3129
    PubMedGoogle Scholar
  • 100 Johnstone EB, Rosen MP, Neril R , et al. The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab 2010; 95 (11) 4965-4972
    CrossrefPubMedGoogle Scholar
  • 101 Villarroel C, Merino PM, López P , et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone. Hum Reprod 2011; 26 (10) 2861-2868
    CrossrefPubMedGoogle Scholar
  • 102 Williams RM, Ong KK, Dunger DB. Polycystic ovarian syndrome during puberty and adolescence. Mol Cell Endocrinol 2013; 373 (1–2) 61-67
    CrossrefPubMedGoogle Scholar
  • 103 Chen Y, Yang D, Li L, Chen X. The role of ovarian volume as a diagnostic criterion for Chinese adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2008; 21 (6) 347-350
    CrossrefPubMedGoogle Scholar
  • 104 Yoo RY, Sirlin CB, Gottschalk M, Chang RJ. Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study. Fertil Steril 2005; 84 (4) 985-995
    CrossrefPubMedGoogle Scholar
  • 105 Eilertsen TB, Vanky E, Carlsen SM. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?. Hum Reprod 2012; 27 (8) 2494-2502
    CrossrefPubMedGoogle Scholar
  • 106 Huang G, Coviello A. Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes 2012; 19 (6) 512-519
    CrossrefPubMedGoogle Scholar
  • 107 Hoeger KM, Oberfield SE. Do women with PCOS have a unique predisposition to obesity?. Fertil Steril 2012; 97 (1) 13-17
    CrossrefPubMedGoogle Scholar
  • 108 Nicandri KF, Hoeger K. Diagnosis and treatment of polycystic ovarian syndrome in adolescents. Curr Opin Endocrinol Diabetes Obes 2012; 19 (6) 497-504
    CrossrefPubMedGoogle Scholar
  • 109 Glueck CJ, Morrison JA, Daniels S, Wang P, Stroop D. Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years. J Pediatr 2011; 159 (2) 308-313 , e2
    CrossrefPubMedGoogle Scholar
  • 110 Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. Glucose intolerance in polycystic ovary syndrome—a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007; 92 (12) 4546-4556
    CrossrefPubMedGoogle Scholar
  • 111 Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87 (3) 1017-1023
    CrossrefPubMedGoogle Scholar